Invesaro

Stocks SHOE Financial statements

Financial statements

SHOE STATION GROUP INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SHOE STATION GROUP INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2017FY2018FY2020FY2021FY2021FY2022FY2023FY2024FY2025
Revenue1,0011,0191,0301,0379771,3301,2621,1761,2031,135
Cost of revenue712723721725697804794754774720
Gross profit289296309312280527468421429415
Selling, general and administrative251259259258258319322328338348
General and administrative58.459.664.769.5
Operating income37.937.749.854.221.920814693.591.266.8
Interest expense0.170.290.150.190.410.480.290.280.310.37
Interest income0.0100.750.730.10.020.972.923.614
Other non-operating income003.040
Pre-tax income37.737.450.454.721.620714796.197.570.4
Income tax14.218.512.211.85.5652.337.122.823.718.1
Net income23.518.938.142.91615511073.373.852.3
EBITDA61.661.571.671.238226170122122101
EPS, basic0.640.581.261.490.575.494.002.692.721.91
EPS, diluted0.640.581.231.460.565.423.962.682.681.90
Shares, basic (weighted)3632.430.228.928.128.227.527.227.227.3
Shares, diluted (weighted)3632.53129.428.528.627.827.427.527.5
Dividend per share0.140.150.360.440.540.60

Balance sheet

FY2017FY2017FY2018FY2020FY2021FY2021FY2022FY2023FY2024FY2025
Cash and equivalents62.948.36761.910711751.499109117
Short-term investments01511.612.214.413.6
Receivables4.426.271.222.727.114.23.052.599.026.37
Inventory280261258259233285390346386440
Other current assets4.745.5611.55.538.4110.313.321.118.419.4
Total current assets352321337330355442470481536596
Property, plant and equipment96.286.370.667.862.388.5141169173186
Lease right-of-use assets25.8215206221319334344350
Goodwill011.412121818
Intangible assets032.632.632.64140.9
Other non-current assets0.910.540.468.1113.814.115.413.612.711.5
Total assets4584164186286438129901,0421,1241,202
Accounts payable67.841.748.760.757.769.178.958.35279.2
Accrued liabilities18.51522.118.724.433.120.316.625.421.2
Total current liabilities86.356.870.8123131154157128130158
Long-term debt00
Lease liabilities0194183195285301315313
Other non-current liabilities0.830.970.071.053.040.330.170.430.851.29
Total liabilities140108114331333360464459475512
Total debt00
Paid-in capital65.365.575.679.978.780.783.483.790.493.1
Retained earnings313327360396407553653715773809
Treasury stock-59.2-85.1-132-179-176-182-212-215-215-213
Shareholders' equity319307304297310453526583649690
Total equity319307304297310453526583649690
Total liabilities and equity4584164186286438129901,0421,1241,202

Cash flow statement

FY2017FY2017FY2018FY2020FY2021FY2021FY2022FY2023FY2024FY2025
Net income23.518.938.142.91615511073.373.852.3
Depreciation and amortization23.723.821.81716.118.823.228.831.134.3
Stock-based compensation3.825.0210.26.493.885.535.434.897.77.31
Deferred income tax-2.883.92-131.961.6913.64.880.237.61
Change in receivables-2.29-0.953.91-1.51-4.37-6.211.40.46-4.062.62
Change in payables-0.98-30.112.79.472.513.780.93-22.2-10.524.7
Cash from operations63.840.374.166.963.414850.412310371.3
Capital expenditures-21.8-19.7-7.41-18.5-12.4-31.4-77.3-56.3-33.2-44.7
Acquisitions00-70.70.390-44.80
Purchases of investments00-19-0.98-0.4-1.16-2.77
Sales and maturities of investments0.750.31.83.852.051.413.47
Cash from investing-21.8-19.7-4.42-17.8-12.1-119-74-54.6-77.7-44
Stock issued0.220.260.180.180.20.160.190.180.170.17
Share buybacks-42.6-29.8-46-37.80-7.15-30.5-5.4500
Dividends paid-5.03-4.82-4.76-5.67-5.13-8-9.97-12.2-14.7-16.7
Cash from financing-47.8-35.4-51-54.3-6.67-17.7-42.5-20.5-15.3-18.9
Net change in cash-5.87-14.718.8-5.1244.610.9-66.147.69.688.41
Free cash flow4220.766.748.451117-26.966.569.526.6
Interest paid0.170.290.150.190.390.480.30.280.280.28
Income taxes paid14.716.813.49.813.1450.523.919.221.210.7

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to August 1, 2026; growth uses fiscal years. Valuation uses the share price of $13.00 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin34.5%Gross profit / revenue.
Operating margin2.8%Operating income / revenue.
EBITDA margin6.0%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin3.2%Pre-tax income / revenue.
Net margin2.2%Net income / revenue.
FCF margin6.0%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin9.2%Cash from operations / revenue.
Effective tax rate30.4%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)3.6%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)2.1%Net income / average total assets.
Return on invested capital (ROIC)3.9%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue31.7%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue3.2%Capital expenditures / revenue.
D&A / revenue3.2%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-5.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-3.5%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y3.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-3.2%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-3.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y8.2%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-26.8%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-23.0%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y25.0%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-17.3%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-15.8%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y21.6%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-29.1%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-22.0%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y26.7%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-29.1%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-21.7%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y27.7%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-30.5%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y12.2%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y2.4%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-61.7%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y-12.2%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y11.1%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y18.6%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y6.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y9.5%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y17.3%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y6.9%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y6.7%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y13.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.3%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio4.04xCurrent assets / current liabilities.
Quick ratio0.94x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.90x(Cash + short-term investments) / current liabilities.
Liabilities / assets42.0%Total liabilities / total assets.
Interest coverage79.2xOperating income / interest expense.
Working capital$444.6MCurrent assets - current liabilities.
Goodwill and intangibles / assets5.0%(Goodwill + intangible assets) / total assets.
Tangible book value$617.9MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.95xRevenue / average total assets.
Fixed asset turnover6.38xRevenue / average property, plant and equipment.
Inventory turnover1.70xCost of revenue / average inventory.
Days inventory215 days365 x average inventory / cost of revenue.
Receivables turnover177xRevenue / average receivables.
Days sales outstanding2 days365 x average receivables / revenue.
Days payables36 days365 x average accounts payable / cost of revenue.
Cash conversion cycle180 daysDays inventory + days sales outstanding - days payables.
FCF conversion273.5%Free cash flow / net income, when net income is positive.
Capex / operating cash flow34.6%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.89Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$40.50Revenue / diluted weighted shares.
FCF per share$2.44Free cash flow / diluted weighted shares.
Operating cash flow per share$3.73Cash from operations / diluted weighted shares.
Book value per share$24.78Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$22.62Tangible book value / shares outstanding.
Cash per share$4.82(Cash + short-term investments) / shares outstanding.
Payout ratio73.4%Dividends paid / net income, when net income is positive.
Dividends / FCF26.8%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$353.0MShare price x shares outstanding.
Enterprise value$221.3MMarket cap + total debt - cash - short-term investments.
P/E14.5xMarket cap / net income. Only when net income is positive.
P/S0.32xMarket cap / revenue.
P/B0.52xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book0.57xMarket cap / tangible book value, when positive.
P/FCF5.30xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF3.47xMarket cap / cash from operations, when positive.
EV/Sales0.20xEnterprise value / revenue.
EV/EBIT7.11xEnterprise value / operating income, when both are positive.
EV/EBITDA3.34xEnterprise value / EBITDA, when both are positive.
EV/FCF3.33xEnterprise value / free cash flow, when both are positive.
FCF yield18.9%Free cash flow / market cap.
Earnings yield6.9%Net income / market cap (the inverse of P/E).
Dividend yield5.1%Dividends paid over the period / market cap.
Shareholder yield5.1%(Dividends paid + share buybacks) / market cap.
What was SHOE STATION GROUP INC's revenue in fiscal 2025?

SHOE STATION GROUP INC reported revenue of $1.14B for fiscal 2025, 5.6% lower than the year before.

Was SHOE STATION GROUP INC profitable in fiscal 2025?

Yes. Net income was $52.3M, a net margin of 4.6%.

How much free cash flow did SHOE STATION GROUP INC generate in fiscal 2025?

Cash from operations of $71.3M minus capital expenditures of $44.7M left free cash flow of $26.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SHOE STATION GROUP INC